title: Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy.
authors.forename: Tim R
authors.initials: TR
authors.lastname: Cressey
authors.forename: Prattana
authors.initials: P
authors.lastname: Leenasirimakul
authors.forename: Gonzague
authors.initials: G
authors.lastname: Jourdain
authors.forename: Yardpiroon
authors.initials: Y
authors.lastname: Tawon
authors.forename: Pra-Ornsuda
authors.initials: PO
authors.lastname: Sukrakanchana
authors.forename: Marc
authors.initials: M
authors.lastname: Lallemant
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D019540:Area Under Curve; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006207:Half-Life; D006801:Humans; D017410:Practice Guidelines as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015215:Zidovudine / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine